Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. The index has shown a price loss of -41.61% this year. Over the last six months, there has been a stronger performance of -18.63%. The price of PFE leaped by -4.07% during the last 30 days period. For the last 5-days stocks have improved 1.49%.
The present stock price for Pfizer Inc. (PFE) is $29.92. In the last trading session, the stock made a considerable jump, reaching $30.0089 after an opening price of $29.92. The stock briefly fell to $29.74 before ending the session at $29.77.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
Pfizer Inc. experienced a rather shaky stock market performance. The highest value in the past year was recorded at $54.93 on 12/14/22 and the lowest value was $28.93 on 11/13/23.
52-week price history of PFE Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Pfizer Inc.’s current trading price is -45.53% away from its 52-week high, while its distance from the 52-week low is 3.42%. The stock’s price range during this period has varied between$28.93 and $54.93. The Pfizer Inc.’s shares, which operate in the Healthcare, saw a trading volume of around 26.95 million for the day, a figure considerably lower than their average daily volume of 28.39 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Pfizer Inc. (PFE) has experienced a quarterly decline of -19.16% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 168.94B and boasts a workforce of 83000 employees.
Pfizer Inc.: Analysts’ Ratings Unveiled
As of right now, 11 analysts are rating Pfizer Inc. as a BUY, 1 of the polled analysts branded the stock as an OVERWEIGHT, 14 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 33.99, with a change in price of -6.37. Similarly, Pfizer Inc. recorded 26,698,541 in trading volume during the last 100 days, posting a change of -17.55%.
PFE’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for PFE stands at 0.66. Similarly, the long-term debt-to-equity ratio is also 0.63.
PFE Stock Stochastic Average
Pfizer Inc.’s raw stochastic average for the past 50 days is presently 17.40%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 39.92%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 40.97% and 30.42%, respectively.
